Latest News
A new Yale study investigates how cortisol, a stress-related hormone, helps the brain build emotional memories.
- January 14, 2025Source: The Oprah Podcast
In this episode of The Oprah Podcast, Oprah sits down with Dr. Ania Jastreboff, an endocrinologist and associate professor at the Yale School of Medicine, to talk about the new GLP-1 medications like Ozempic, Wegovy, Mounjaro and Zepbound. Dr. Ania, who has been on the forefront of GLP-1 medication research for the past 20 years, will talk through why it is biologically difficult for some people to lose weight, maintain weight loss, and why obesity is a disease. She explains how the new GLP-1 medications work, how they can facilitate weight loss, and if they are safe. Dr. Ania answers questions from people around the country who are taking the GLP-medications and have lost a significant amount of weight. We will also share an update from Amy Kane who told her story of losing 160 pounds on weight loss medications last year on Oprah’s ABC Special: Shame, Blame and the Weight Loss Revolution.
- August 06, 2024Source: The New York Times
Rajita Sinha, PhD, Foundations Fund Professor of Psychiatry and Professor in the Child Study Center and of Neuroscience, and director of the Yale Interdisciplinary Stress Center, spoke to The New York Times about the effect of stress on a person's appearance.
- March 06, 2024
Newly emerging, highly effective treatments and new discoveries regarding the pathophysiology of obesity provide promise for combating this growing epidemic.
- October 23, 2023Source: Yale Medicine
Prediabetes is a warning sign that your body's insulin levels are rising. Yale Medicine experts discuss how to reverse it before developing type 2 diabetes.
- March 22, 2023Source: New York Times
Cortisol gets a bad rap, but it’s not so clear-cut.
- December 14, 2022Source: New England Journal of Medicine
Ania Jastreboff, MD, PhD talks about obesity.
- November 20, 2022
The Yale School of Public Health’s annual Dean’s Lecture and Program on Aging seminar was delivered this year by Harvard Professor David Grabowski, a leading national expert in health care policy and long-term care.
- October 14, 2022Source: Medscape
New insights into the benefits of treatment with the "twincretin" tirzepatide for people with overweight or obesity come from new findings reported at the annual meeting of the European Association for the Study of Diabetes.
- October 12, 2022Source: Newsweek
YCSC experts including Professor Wendy Silverman, PhD, ABPP discuss anxiety treatment with Newsweek.